Donors at the Global Fund's sixth annual conference have pledged a record-breaking $14 billion for the next three years – the largest amount ever raised for an organization of this kind.
Set up to accelerate research aimed at ending epidemics of AIDS, tuberculosis and malaria, the Global Fund is a partnership between governments, civil society, the private sector and people affected by the diseases.
Speaking at the conference, French President Emmanuel Macron called on all partners to increase their commitments by at least 15% in order to reach the target.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze